METHOTREXATE REDUCES ADALIMUMAB IMMUNOGENICITY IN PATIENTS WITH SPONDYLOARTHRITIS: A RANDOMIZED CLINICAL TRIAL

被引：1
|
作者：
Ducourau, E. [1 ,2 ,3 ]
Rispens, T. [4 ]
Dernis, E. [5 ]
Le Guilchard, F. [6 ]
Andras, L. [6 ]
Perdriger, A. [7 ]
Lespessailles, E. [3 ]
Martin, A. [8 ]
Cormier, G. [9 ]
Armingeat, T. [10 ]
Devauchelle-Pensec, V. [11 ]
Solau-Gervais, E. [12 ]
Le Goff, B. [13 ]
de Vries, A. [14 ]
Piver, E. [15 ,16 ]
Ternant, D. [17 ,18 ]
Goupille, P. [1 ,2 ]
Mulleman, D. [1 ,2 ]
机构：
[1] Univ Francois Rabelais Tours, CNRS 7292, Rheumatol, Tours, France
[2] CHRU Tours, Rheumatol, Tours, France
[3] CHR Orleans, Rheumatol, Orleans, France
[4] Sanquin Res, Landsteiner Labs, Amsterdam, Netherlands
[5] CH Mans, Rheumatol, Le Mans, France
[6] CH Blois, Rheumatol, Blois, France
[7] CHRU Rennes, Rheumatol, Rennes, France
[8] CH St Brieuc, Rheumatol, St Brieuc, France
[9] CH la Roche Sur Yon, Rheumatol, La Roche Sur Yon, France
[10] CH St Nazaire, Rheumatol, St Nazaire, France
[11] CHRU Brest, Rheumatol, Brest, France
[12] CHRU Poitiers, Rheumatol, Poitiers, France
[13] CHRU Nantes, Rheumatol, Nantes, France
[14] Sanquin Diagnost Serv, Biol Lab, Amsterdam, Netherlands
[15] Univ Francois Rabelais Tours, Inserrn, U955, Biochem, Tours, France
[16] CHRU Tours, Biochem, Tours, France
[17] Univ Francois Rabelais Tours, Pharmacol Toxicol, CNRS 7292, Tours, France
[18] CHRU Tours, Pharmacol Toxicoloy, Tours, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0349
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [1] The Effect of Sulfasalazine and Methotrexate on the Immunogenicity of Infliximab and Adalimumab in Patients with Spondyloarthritis
    Martinez, Ana
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Kneepkens, Eva L.
    Wolbink, Gertjan
    Villalba, Alejandro
    Jurado, Teresa
    Peiteado, Diana
    Nuno, Laura
    Jochems, Andrea
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] METHOTREXATE REDUCES IMMUNOGENICITY IN ADALIMUMAB TREATED RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 101 - 102
  • [3] Combination with Methotrexate reduces Immunogenicity against Adalimumab
    Krome, Susanne
    AKTUELLE DERMATOLOGIE, 2023, 49 (01/02) : 12 - 12
  • [4] Randomized Controlled Trial of Adalimumab in Patients with Peripheral Spondyloarthritis
    Rahman, Proton
    Sieper, Joachim
    van den Bosch, Filip
    Obermeyer, Katie
    Pangan, Aileen
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 982 - 982
  • [5] Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis
    Mease, Philip
    Sieper, Joachim
    Van den Bosch, Filip
    Rahman, Proton
    Karunaratne, P. Mahinda
    Pangan, Aileen L.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (04) : 914 - 923
  • [6] Randomized Controlled Trial of Adalimumab in Patients with Peripheral Spondyloarthritis.
    Mease, Philip
    Sieper, Joachim
    Van den Bosch, Filip
    Rahman, Proton
    Obermeyer, Katie
    Pangan, Aileen L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S248 - S249
  • [7] Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
    Ducourau, Emilie
    Rispens, Theo
    Samain, Marine
    Dernis, Emmanuelle
    Le Guilchard, Fabienne
    Andras, Lucia
    Perdriger, Aleth
    Lespessailles, Eric
    Martin, Antoine
    Cormier, Gregoire
    Armingeat, Thomas
    Devauchelle-Pensec, Valerie
    Gervais, Elisabeth
    Le Goff, Benoit
    de Vries, Annick
    Piver, Eric
    Paintaud, Gilles
    Desvignes, Celine
    Ternant, David
    Watier, Herve
    Goupille, Philippe
    Mulleman, Denis
    RMD OPEN, 2020, 6 (01):
  • [8] Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
    Krieckaert, Charlotte L.
    Nurmohamed, Michael T.
    Wolbink, Gerrit Jan
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1914 - 1915
  • [9] Effect of Methotrexate on the Immunogenicity of TNF Inhibitors in Spondyloarthritis Patients.
    Villalba, Alejandro
    Plasencia-Rodriguez, Chamaida
    Peiteado, Diana
    Nuno, Laura
    Bonilla, Gema
    Balsa, Alejandro
    Martin-Mola, Emilio
    Pascual-Salcedo, Dora
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S708 - S708
  • [10] Adalimumab is effective in patients with preradiographic axial spondyloarthritis: Results of a 12-week, randomized controlled trial
    Haibel, H.
    Rudwaleit, M.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    RHEUMATOLOGY, 2007, 46 : I52 - I52
12345